Business · 19/11/20261 min read
Implantica publishes Interim Report January - September 2026 (Q3)
Summary
VADUZ, Liechtenstein, Nov. 19, 2026 — FDA approval secured and first U.S. patients treated at USC Significant events in the third quarter of 2026 FDA Premarket Approval (PMA) granted for RefluxStop® on August 20, opening the world's largest medical device market and enabling...